A Stanford Medicine article examines CRISPR, the gene-editing technology, and addresses its potential to help with conditions such as sickle-cell disease.
Category: Stanford Medicine
Big bacteria may be easier to kill, new research suggests
Stanford researchers have discovered a genetic "tuning knob" that can enlarge or shrink bacteria across a wide range - and this can be used to fatten up the bacteria to increase their susceptibility to certain antibiotics.
How a special school helps keep Packard Children’s patients on track
Packard Children’s hospital school is a unique collaboration between the Palo Alto Unified School District and the hospital, offering a fully accredited academic curriculum for patients grades K-12.
Inventing the future: How scientific discovery can have exponential impact
The Stanford Medicine Discovery Innovation Awards provide funding to support early-stage, creative research, fueling scientific discoveries.
Advances offer new hope for stroke survivors
Seventeen million Americans live with the aftermath of stroke, including difficulty communicating, moving around, and taking care of their most basic needs. Now, Stanford researchers are working to give those survivors new hope.
Happy Match Day!
Each year, during Match Day, medical students across the country find out where they'll be doing their residencies.
Breaking down diabetes: Insulin, unwelcome, but underutilized
In this Breaking Down Diabetes installment, physician-research Randall Stafford clarifies the pros and cons of insulin use in Type 2 diabetes.
Stanford researchers probe the ethics of using artificial intelligence in medicine
Physicians should consider the ethical challenges of using artificial intelligence in making patient care decisions, three Stanford University School of Medicine researchers say in a perspective piece in The New England Journal of Medicine.
Crying my way through a difficult patient encounter
In this piece, first-year medical student Orly Farber talks about controlling her emotions is a clinical setting.
“Brain balls” let scientists mimic, study neurodevelopmental disorders in a dish
The human brain, and how it works, is one of the great mysteries of science. If only you could grow a brain in a bottle, you could learn a lot about what can go wrong – or for that matter, what goes right – in early brain development. So that's why Sergiu Pasca did.
Stanford symposium illuminates how stem cell therapies interact with their surroundings
Reaping stem cells’ full therapeutic benefits requires a detailed understanding of the complex relationships between the cells and their environments -- whether in a lab dish or a patient’s body.
New imaging agent could help personalize lung cancer treatment
A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.
Why Frankenstein matters, now, to you
Stanford anesthesiologist and writer Audrey Shafer reflects on the importance of considering the scientific and ethical issues raised by Frankenstein.
Stanford Presence Center symposium grapples with balancing human and artificial intelligence in medicine
Stanford’s Abraham Verghese believes there should be a more nuanced conversation around what artificial intelligence can do for doctors.
Advanced cell-labeling technology identifies suspect cell type, possible new therapeutic approach to multiple sclerosis
Researchers have identified an immune cell type with an apparently critical role in multiple sclerosis, and a way to block its entry into the brain.
Social media gives early clues to adverse drug reactions in cancer, Stanford researchers find
A group of researchers identified adverse and previously unknown drug reactions by sifting through millions of social health forum posts.